We identified that PEGIL11 treatment significantly regulated the placental production of multiple factors previously associated with preeclampsia including alpha-fetoprotein, angiotensinogen, apolipoproteins A1 and B, and vitamin D receptor (Figure 4K). The gene discussed is AFP; the disease is preeclampsia.